FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36739111000001104: Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Mar 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112581101000001115 Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112581201000001110 Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Is a Gliclazide 40mg tablets true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Has active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has AMP True Gliclazide 40mg tablets (Flamingo Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start